Prophylactic Central Neck Dissection for Papillary Thyroid Cancer

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether prophylactic central neck dissection is beneficial for patients with papillary thyroid cancer staged preoperatively as node negative.

Clinical Trial Description

Several respected organizations have recently recommended that total thyroidectomy plus prophylactic central neck dissection should be the standard operation for papillary thyroid cancer. However, it is still unclear if this approach has any benefit on survival or locoregional control of the disease. In addition, potential advantages of this more aggressive surgical approach should outweigh the risk of morbidity. The purpose of this retrospective cohort study is to determine whether prophylactic central neck dissection is beneficial for patients with papillary thyroid cancer staged preoperatively as node negative. In this study outcomes of total thyroidectomy versus this plus prophylactic central neck dissection for papillary thyroid cancer are compared in a 10-year follow-up. Patients operated between 1993 and 1997 (n=282) underwent total thyroidectomy alone, whereas patients operated between 1998 and 2002 (n=358) underwent total thyroidectomy plus prophylactic central neck dissection. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01510002
Study type	Interventional
Source	Jagiellonian University
Contact
Status	Completed
Phase	N/A
Start date	January 1993
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01441154` - Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Active, not recruiting	`NCT04544111` - PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer	Phase 2
Recruiting	`NCT03469011` - A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.	Phase 1
Recruiting	`NCT05752669` - Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
Recruiting	`NCT04076514` - The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma
Active, not recruiting	`NCT01723202` - Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer	Phase 2
Recruiting	`NCT05500508` - Oral AMXT 1501 Dicaprate in Combination With IV DFMO	Phase 1/Phase 2
Active, not recruiting	`NCT02568267` - Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)	Phase 2
Unknown status	`NCT02140476` - Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy	N/A
Recruiting	`NCT06286631` - Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
Completed	`NCT06325787` - Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma	N/A
Terminated	`NCT01974284` - Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma	N/A
Active, not recruiting	`NCT00984191` - Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid	N/A
Active, not recruiting	`NCT04731467` - A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT05668962` - Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC	Phase 2
Completed	`NCT02178345` - Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Completed	`NCT03470259` - Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging	Phase 1
Active, not recruiting	`NCT04129411` - Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation	N/A
Recruiting	`NCT03899792` - A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors	Phase 1/Phase 2
Completed	`NCT05873283` - Papillary Thyroid Cancer and Central Lymp Node Dissection